Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients

Neuropsychobiology

Volumn 34, Issue 4, 1996, Pages 184-187

  Marazziti, Donatella ^a   Rossi, Alessandra ^a   Gemignani, Alfredo ^a   Giannaccini, Gino ^a   Pfanner, Chiara ^a   Milanfranchi, Alessandro ^a   Presta, Silvio ^a   Lucacchini, Antonio ^a   Cassano, Giovanni B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

3H paroxetine; Blood platelets; Obsessive compulsive disorder; Serotonin; Serotonin transporter

Indexed keywords

CARRIER PROTEIN; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; MEMBRANE PROTEIN; NERVE PROTEIN; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; MALE; OBSESSION; PRIORITY JOURNAL; SEROTONIN UPTAKE; THROMBOCYTE; ADOLESCENT; BRAIN; METABOLISM; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADOLESCENT; ADULT; BLOOD PLATELETS; BRAIN; CARRIER PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OBSESSIVE-COMPULSIVE DISORDER; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029658172     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119308     Document Type: Article

References (36)

1. Montgomery SA: Pharmacological treatment of obsessive-compulsive disorder; in Hollander E. Zohar J, Marazziti D, Olivier B (eds): Current Insights in Obsessive-Compulsive Disorder. Chichester. Wiley. 1994, pp 215-226.
2. Piccinelli M, Pini S, Bellantuono C, Wilkinson C: Efficacy of drug treatment in obsessive-compulsive disorder. Br J Psychiatry 1995:166: 424-443.
3. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL: Obsessive-compulsive disorder and serotonin: Is there a conncection? Biol Psychiatry 1985:20:1174-1188.
4. Thoren P, Asberg M, Cronholm B: Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Arch Gen Psychiatry 1980;37:1281-1289.
5. Asberg M, Thoren P, Bertilsson L: Clomipramine treatment of obsessive disorder: Biochemical and clinical aspects. Psychopharmacol Bull 1981:18:13-21.
6. Zohar J, Insel TR: Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 1987:22:667-687.
7. Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR: Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings. Arch Gen Psychiatry 1988;145:1015-1023.
8. Wolf WA, Kuhn DM: The 5-HT transporter is an additional site of action for the 5-HT agonist RU 24969 and TFMPP. Neurochem Int 1991; 19:39-44.
9. Zohar J, Insel TR, Zohar-Kadouch RC, Hill J, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder. Effect of chronic clomipramine treatment. Arch Gen Psychiatry 1988;45:167-172.
10. Lesch KP: 5HTI receptors in depression and related disorders. Eur Neuropsychopharmacol 1993:3:302-303.
11. Weizman R, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M: High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 1986;143:335-339.
12. Black DW, Kelly M, Myers C, Noyes R Jr: Tri-tiated imipramine binding in obsessive-compulsive volunteers and psychiatricallv normal controls. Biol Psychiatry 1990:27:319-327.
13. Bastani B, Arora RC, Meltzer HY: Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry 1991;30:131-139.
14. Viticllo B, Shimon H, Behar D, Stoff D, Bridger WH, Friedman E: Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients. Acta Psychiatr Scand 1991:84: 29-32.
15. Marazziti D, Hollander E, Lensi P, Ravagli S, Cassano GB: Peripheral marker of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Res 1992:42:41-51.
16. Rausch JJ, Hutchinson J, Li X: Correlations of drug action between human platelets and human brain 5HTT. Biol Psychiatry (suppl) 1995; 137:600.
17. 3H-imipraminc binding sites. Eur J Pharmacol 1985:106:669-672.
18. 3H-imipramine and the serotonin transporter in human platelets. J Neurochem 1987;48:560-565.
19. 3H-imipra-mine binding in intact human platelets. Biol Psychiatry 1989:25:576-584.
20. Halbreich U, Rojansky N, Zander KJ, Barkai A: Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J Psychiatr Res 1991;25:7-18.
21. 3H-imipra-mine to protease-sensitive and protease-resistant sites. J Neurochem 1985:44:705-711.
22. 3H-imipraminc binding based on ion dependence and serotonin sensitivity. J Neurochem 1986:46:1743-1754.
23. 3H-imip-raminc to human platelet membranes. Eur J Pharmacol 1983:96:303-309.
24. Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington. American Psychiatric Association. 1994.
25. Goodman WK, Price LH, Rasmussen SA: The Yale Brown Obsessive-Compulsive Scale I: Development, use and reliability. Arch Gen Psychiatry 1986:46:1006-1011.
26. Hamilton M: A rating scale for depression. J Neurol Ncurosurg Psychiatry 1980:23:189-192.
27. McPherson GA: Kinetic. EBDA. Ligand. Lowry: A collection of radio ligand binding analysis programs. Cambridge. Biosoft. 1985.
28. Marcusson JO, Baeckstroem I, Ross SB: Singlesite model of the neuronal 5-hydroxytrvpta-mine uptake and imipramine binding site. Mol Pharmacol 1986;30:121-128.
29. 3]H-paroxctinc binding to platelets from healthy volunteers. Biol Psychiatry 1993;34:356-360.
30. 3H-paroxetine binding in depressed patients. Psychiatry Res 1988,26:11-17.
31. 3H]-paroxetine. Psychopharmacology 1993:110:235-239.
32. 3H]-paroxetine binding to platelets of patients with social phobia: Comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 1995:37:224-228.
33. 3H-imipra-mine binding in panic disorder patients and healthy controls. J Psychiatry Neurosci 1994; 19:109-113.
34. [3]H-paroxe-tinc binding in panic disorder. J Affect Disord 1995:33:117-122.
35. 3H-imipramine binding as a predictor of treatment response. Paper presented at the 31st meeting of the American College of Neuropsychopharmacology. San Juan, December 14-18, 1992. p 66.
36. Castrogiovanni P, Di Muro A, Marazziti D: Imipramine binding as a receptor of fluoxetine response in depressed patients. Neuropsychobiology 1995;31:64-67.